IBDEI1K8 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27694,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,27694,1,5,0)
 ;;=5^CVA w/ Hemiplegia (Late Effect)
 ;;^UTILITY(U,$J,358.3,27694,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,27695,0)
 ;;=438.12^^162^1786^5
 ;;^UTILITY(U,$J,358.3,27695,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27695,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,27695,1,5,0)
 ;;=5^CVA w/ Dysphasia (Late Effect)
 ;;^UTILITY(U,$J,358.3,27695,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,27696,0)
 ;;=356.8^^162^1786^51
 ;;^UTILITY(U,$J,358.3,27696,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27696,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,27696,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,27696,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,27697,0)
 ;;=337.20^^162^1786^58
 ;;^UTILITY(U,$J,358.3,27697,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27697,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,27697,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,27697,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,27698,0)
 ;;=294.8^^162^1786^19
 ;;^UTILITY(U,$J,358.3,27698,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27698,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,27698,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,27698,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,27699,0)
 ;;=438.6^^162^1786^4
 ;;^UTILITY(U,$J,358.3,27699,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27699,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,27699,1,5,0)
 ;;=5^CVA w/ Dysesthesia (Late Effect)
 ;;^UTILITY(U,$J,358.3,27699,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,27700,0)
 ;;=438.7^^162^1786^7
 ;;^UTILITY(U,$J,358.3,27700,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27700,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,27700,1,5,0)
 ;;=5^CVA w/ Vision Changes (Late Effect)
 ;;^UTILITY(U,$J,358.3,27700,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,27701,0)
 ;;=438.84^^162^1786^3
 ;;^UTILITY(U,$J,358.3,27701,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27701,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,27701,1,5,0)
 ;;=5^CVA w/ Ataxia (Late Effect)
 ;;^UTILITY(U,$J,358.3,27701,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,27702,0)
 ;;=434.91^^162^1786^8
 ;;^UTILITY(U,$J,358.3,27702,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27702,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,27702,1,5,0)
 ;;=5^CVA,Acute Onset
 ;;^UTILITY(U,$J,358.3,27702,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,27703,0)
 ;;=V12.54^^162^1786^22
 ;;^UTILITY(U,$J,358.3,27703,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27703,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,27703,1,5,0)
 ;;=5^HX Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,27703,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,27704,0)
 ;;=333.94^^162^1786^59
 ;;^UTILITY(U,$J,358.3,27704,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27704,1,4,0)
 ;;=4^333.94
 ;;^UTILITY(U,$J,358.3,27704,1,5,0)
 ;;=5^Restless Leg Syndrome
 ;;^UTILITY(U,$J,358.3,27704,2)
 ;;=^105368
 ;;^UTILITY(U,$J,358.3,27705,0)
 ;;=345.90^^162^1786^62
 ;;^UTILITY(U,$J,358.3,27705,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27705,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,27705,1,5,0)
 ;;=5^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,27705,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,27706,0)
 ;;=339.00^^162^1786^10
 ;;^UTILITY(U,$J,358.3,27706,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27706,1,4,0)
 ;;=4^339.00
 ;;^UTILITY(U,$J,358.3,27706,1,5,0)
 ;;=5^Cluster Headache NOS
 ;;^UTILITY(U,$J,358.3,27706,2)
 ;;=^336741
 ;;
 ;;$END ROU IBDEI1K8
